News

Ceftolozane and tazobactam proves noninferior to meropenem in a pivotal phase 3 trial of adult patients with HABP or VABP.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A large outbreak of infections caused by the yeast Candida auris remains ongoing in health care facilities in New York City and poses a concerning public health threat.

Common skin bacteria have gained resistance to multiple antibiotics.

When it comes to HPV infection in men who have sex with men, the type of virus they contract has real implications for their future cancer risk.

Public Health England recommends individuals at higher risks for influenza receive a newly available adjuvanted trivalent influenza vaccine this winter.

A new study is the first to identify eosinophil counts as a predictor of outcomes in human patients.

The US Preventative Services Task Force recommends early screening for syphilis in pregnant women and a literature review has reinforced the recommendations.

Investigators from the NIH have launched a phase 1 clinical trial to assess if a topical cream administered prior to H5N1 vaccination can enhance immune response.

Local officials tout benefits of needle exchange, testing programs at reducing risk.

A new study underscores components to antimicrobial resistance that we may be ignoring.

An international literature review indicates that 78% of children with multidrug-resistant tuberculosis were successfully treated with second-line treatment.

In a new study, investigators found that providing guidance and advice in people who inject drugs increased use of antiretroviral medication use by 30%.

The CDC and FDA are investigating a multistate outbreak of Salmonella Enteritidis linked with Gravel Ridge Farms shell eggs.

A team of investigators have discovered a new way to link samples submitted for TB testing to individuals who provided them as well as where the sample was collected.

Study results suggest that treatment with the anti-inflammatory steroid dexamethasone is associated with slowed clearance of fungal infections in HIV-associated cryptococcal meningitis.

Findings from a pair of studies from investigators in Israel suggest that probiotic supplements may not be as beneficial as previously thought.

Results of the 2016 European Gonococcal Antimicrobial Surveillance Program report a steady rise in drug resistant-gonorrhea infections.

A treatment comprised of DOR/3TC/TDF was non-superior to EFV/FTC/TDF for primary efficacy but resulted in fewer adverse events.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The FDA has approved Grifols’ new formulation of immune globulin (GamaSTAN) for hepatitis A virus and measles post-exposure prophylaxis.

A Legionnaires’ disease outbreak in New Hampshire has been linked to at least 1 resort in the town of Hampton.

Do ancient medicinal treatments hold potential for future antimicrobial efforts?

New research finds that the flu vaccine is more successful in women than in men, but the complexity of the issue makes it difficult to know exactly why that is.

Strands of hair have several advantages over plasma samples in revealing whether a person with HIV is adhering to a medication regimen.

Ebola is not the only infectious disease that health officials in the Democratic Republic of the Congo are struggling with.

The conventional approach to fighting resistant E coli infections typically involves the use of no more than 2 antibiotics; however, combining as many as 5 may be the trick to fighting these infections.

Investigators have found that a strain of E coli found in retail poultry products can cause a wide range of infections in people.

New practical advice for the treatment of C difficile from SHEA advises against routine testing in NICU patients with diarrhea.